Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205

Ependymoma

HER2-specific CAR T Cells for Children With Ependymoma ONC206 for Treatment of Newly Diagnosed or Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant Brain Tumors (PNOC 023) Study of the Effect of GM-CSF on Macrophages in Ependymoma A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors HUMC 1612: Optune NovoTTF-200A System Treatment of Children With Recurrent Refractory Brain/Solid Tumors and Recurrent Ependymoma Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205 Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma Immunotherapy for Recurrent Ependymomas in Children Treatment for Recurrent Ependymomas Using HLA-A2 Restricted Tumor Antigen Peptides in Combination With Imiquimod LET Optimized IMPT in Treating Pediatric Patients With Ependymoma Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Patients With Recurrent Posterior Fossa Ependymoma Antineoplaston Therapy in Treating Patients With Ependymoma Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma Feasibility Trial of Optune for Children With Recurrent or Progressive Supratentorial High-Grade Glioma and Ependymoma An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma Everolimus for Children With Recurrent or Progressive Ependymoma